Technical Analysis for WGS - GeneDx Holdings Corp.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 24.02 | 13.52% | 2.86 |
WGS closed up 13.52 percent on Thursday, May 16, 2024, on 1.25 times normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Very Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing High | Bullish | 0.00% | |
| 180 Bullish Setup | Bullish Swing Setup | 0.00% | |
| New 52 Week High | Strength | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Slingshot Bullish | Bullish Swing Setup | 13.52% | |
| NR7 | Range Contraction | 13.52% | |
| Wide Bands | Range Expansion | 13.52% | |
| Overbought Stochastic | Strength | 13.52% |
| Alert | Time |
|---|---|
| New 52 Week High | about 10 hours ago |
| Up 10% | about 10 hours ago |
| 60 Minute Opening Range Breakout | about 14 hours ago |
| Up 1 ATR | about 14 hours ago |
| Gapped Up (Full) | about 14 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 06/20/2024
GeneDx delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by one of the world’s largest rare disease data sets.
Sector: Healthcare
Industry: Health Information Services
Keywords: Biology Emerging Technologies Drug Discovery Molecular Biology Genomics Precision Medicine Systems Biology Evidence Based Medicine Personal Genomics
Classification
Sector: Healthcare
Industry: Health Information Services
Keywords: Biology Emerging Technologies Drug Discovery Molecular Biology Genomics Precision Medicine Systems Biology Evidence Based Medicine Personal Genomics
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 24.32 |
| 52 Week Low | 1.16 |
| Average Volume | 451,698 |
| 200-Day Moving Average | 5.97 |
| 50-Day Moving Average | 12.64 |
| 20-Day Moving Average | 17.17 |
| 10-Day Moving Average | 20.87 |
| Average True Range | 1.95 |
| RSI (14) | 74.94 |
| ADX | 53.79 |
| +DI | 39.76 |
| -DI | 5.68 |
| Chandelier Exit (Long, 3 ATRs) | 18.46 |
| Chandelier Exit (Short, 3 ATRs) | 14.63 |
| Upper Bollinger Bands | 26.66 |
| Lower Bollinger Band | 7.67 |
| Percent B (%b) | 0.86 |
| BandWidth | 110.65 |
| MACD Line | 3.19 |
| MACD Signal Line | 2.79 |
| MACD Histogram | 0.3988 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 28.25 | ||||
| Resistance 3 (R3) | 27.88 | 26.10 | 27.55 | ||
| Resistance 2 (R2) | 26.10 | 25.02 | 26.29 | 27.31 | |
| Resistance 1 (R1) | 25.06 | 24.36 | 25.58 | 25.43 | 27.07 |
| Pivot Point | 23.28 | 23.28 | 23.54 | 23.47 | 23.28 |
| Support 1 (S1) | 22.24 | 22.20 | 22.76 | 22.61 | 20.97 |
| Support 2 (S2) | 20.46 | 21.54 | 20.65 | 20.73 | |
| Support 3 (S3) | 19.42 | 20.46 | 20.50 | ||
| Support 4 (S4) | 19.79 |
